Skip to main content

Laplace Interventional

Plymouth, United States

Laplace is a medical device company that develops transcatheter tricuspid valve technology.

$22.0M raised
Mar 2025
Series C

Top Investors

Mayo ClinicShangbay CapitalAphelion CapitalFeatures Capitalgbeta

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Laplace Interventional

How much funding has Laplace Interventional raised?
Laplace Interventional has raised $22.0M in total funding. The most recent round was Series C. The last funding was announced in March 2025.
Who are Laplace Interventional's investors?
Laplace Interventional's investors include Mayo Clinic, Shangbay Capital, Aphelion Capital, Features Capital, gbeta.
Where is Laplace Interventional headquartered?
Laplace Interventional is headquartered in Plymouth, United States.
What does Laplace Interventional do?
Laplace is a medical device company that develops transcatheter tricuspid valve technology.
What stage is Laplace Interventional at?
Laplace Interventional is at the Series C stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Laplace Interventional — Funding & Investors." VCBacked, March 16, 2025, https://www.vcbacked.co/company/laplace-interventional. Accessed June 17, 2026.
APA
VCBacked. (2025). Laplace Interventional — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/laplace-interventional
Wikipedia (cite web)
{{cite web |title=Laplace Interventional — Funding & Investors |url=https://www.vcbacked.co/company/laplace-interventional |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .